VP shunt infections: Difference between revisions
(Created page with "==Background== ===Causative agents=== *S. epi *S. aureus *Coliforms ==Clinical Features== ==Differential Diagnosis== ==Diagnosis== ==Management== ===Pediatric=== {{Pediat...") |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
===Causative agents=== | ===Causative agents=== | ||
*S. epi | *[[S. epi]] | ||
*S. aureus | *[[S. aureus]] | ||
*Coliforms | *Coliforms | ||
Revision as of 04:34, 6 June 2015
Background
Causative agents
Clinical Features
Differential Diagnosis
Diagnosis
Management
Pediatric
- Empiric therapy: Vancomycin AND Cefotaxime 200 mg/kg/day IV div Q6 OR ceftriaxone 100 mg/kg/day IV div Q12-24
- Always involved neurosurgery in management
- Tailor antimicrobial therapy to culture results